AstraZeneca And Genzyme Breach Industry Code Of Practice
AstraZeneca and Genzyme have been named in advertisements for separate breaches of the Association of the British Pharmaceutical Industry's code of practice.
You may also be interested in...
The UK industry body the Association of the British Pharmaceutical Industry (ABPI) has suspended Astellas UK as a member for one year following serious breaches of its code of practice for the pharmaceutical industry.
The UK's main reimbursement bodies made a series of decisions this week that were broadly favorable and largely focused on oncology medicines.
While troubled Valeant was divesting iNova to private equity investors, Novartis announced a pair of oncology-focused deals, out-licensing a brain cancer drug to Midatech and partnering with IBM Watson Health to optimize breast cancer treatment.